Shout out to CanyousayThanks for taking the time to share some insightful thoughts about the conference call. I listened to it last night and my take was closest to yours. I agree on most of what you said.
I'm still disappointed they didn't mention their trouble sourcing antibodies sooner. But for now, I'm keeping my 25% position and may add on weakness. Look forward to hearing more from the company as Q1 financials draw closer.